HYPERTROPHIC CARDIOMYOPATHY MEDICAL
Data sourced from IRS 990 public filings
HYPERTROPHIC CARDIOMYOPATHY MEDICAL TO BRING TOGETHER AN INNOVATIVE AND PRODUCTIVE COMMUNITY OF PHYSICIANS, SCIENTISTS AND MEDICAL PROVIDERS DEDICATED TO IMPROVING THE DIAGNOSIS AND TREATMENT OF PEOPLE WITH HYPERTROPHIC CARDIOMYOPATHY THROUGH CLINICAL EXCELLENCE, RESEARCH AND EDUCATION.
Annual Revenue
$621,634
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $621,634 | $114,935 | $896,279 |
| 2023 | $283,553 | $187,382 | $405,854 |
| 2022 | $451,102 | $137,550 | $292,080 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
MILIND DESAI MD
DIRECTOR
NICK SMEDIRA MD
DIRECTOR
SARA SABERI MD
TREASURER
AHMAD MASRI MD
DIRECTOR
ANDREW WANG MD
PRESIDENT
ANJALI OWENS MD
DIRECTOR
ANNA WOO MD
DIRECTOR
CAROLYN HO MD
DIRECTOR
EUGENE BRAUNWALD MD
DIRECTOR
HUGH WATKINS MD
DIRECTOR
Showing 10 of 20 key personnel.
Frequently Asked Questions
Other Nonprofits in North Carolina
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.